SlideShare a Scribd company logo
1 of 29
ANTI HIPERTENSI
SRI PURWANINGSIH,dr.,MKes.
Departemen Farmakologi
Kedokteran Unair
ETIOLOGI HT
ESENSIAL : 90%
SEKUNDER : - PENY GINJAL
- TUMOR ADRENAL
- KERACUNAN KEHAMILAN
KOMPLIKASI HT
- ISKEMIA JANTUNG ( PJK )
- GAGAL JANTUNG
- GAGAL GINJAL
- KEBUTAAN (perdarahan retina)
- STROKE ( Cerebro Vasicular Accident )
hipertensi esensial/primer/idiopatik: krn 90% tidak diketahui penyebabnya
hipertensi sekunder: diketahui penyebabnya.
cat:
jika ada vasokonstriksi Resistensi perifer^
SSP
SISTEM SIMPATIS PERIFER
RELEASE NE
STIMULASI JTG VASOKONSTRIKSI
CARDIAC OUTPUT RESIST. PERIFER
TEKANAN DARAH
RENAL BLOOD FLOW
EKSKRESI Na + AIR
RELEASE RENIN
ANGIOTENSINOGEN ANGIOTENSIN I
AngiotensinCorbacte Enzim (dihambat dgan ACE inhibitor)
AT II
VASOKONSTR.
SEKRS. ALDOSTERON
RETENSI Na + AIR (penahanan Natrium)
* RENIN PD : RBF , Na+
, CATHECOLAMIN, PG
* AT II : PR TAPI CO TDK DIPENGARUHI
PATOFISIOLOGI HIPERTENSI
Θ 1, 2
Θ 3
Θ 4, 5
Θ 2, 6
RBF Na+
Θ 7
Θ 8
Θ 9
TX NON FARMAKOLOGIS
1. KURANGI STRESS
2. OLAH RAGA HDL
3. BATASI GARAM
4. BB
5. STOP ROKOK & ALKOHOL
• Ket:
• Diobati dengan Angiotensin blocker.
• 8: dihambat reseptor blocker
• 9: dihambat dengan anti aldosteron
ANTI HIPERTENSIANTI HIPERTENSI
1. α 2 AGONIS : CLONIDIN, METHYLDOPA
2. β BLOCKER : ATENOLOL, METOPROLOL, PROPANOLOL
3. BLOCK NEURON ADRENERGIK : GUANETIDIN
4. α 1 BLOCKER : TERAZOSIN, PRAZOSIN
1 SD 4 RELEASE NE VASOKONSTR
CO
5. VASODILATOR
- Ca ANTAGONIS : NIFEDIPIN, AMLODIPIN, VERAPAMIL,
DILTIAZEM
- DIRECT VASODILATOR : HIDRALAZIN, DIAZOKSID,
MINOKSIDIL, NITROPRUSID
6. DIURETIK ( VOL PLASMA ) : HCT, FUROSEMID
7. ACE INHIBITOR : CAPTOPRIL, ENALAPRIL
8. AT II REC ANTAGONIS “ LOSARTAN
9. BLOK REC ALDOSTERON : SPIRONOLAKTON
CLONIDINE
-STIMULASI α2 DI SSP & PERIFER NE CO PR TEK DRH
-FARMAKOKINETIK :
T ½ 8 – 12 JAM, EKS GINJAL ( 50 % )
LARUT LEMAK, BIOAVAILABILITAS 75 %
-EF SAMPING : SEDASI, MULUT KERING, DEPRESI, KONSTIPASI,
IMPOTENSI, MIMPI BURUK, SYNDR PUTUS OBAT,
POSTURAL HIPOTENSI JARANG
-Postural hipotensi: harus tidur
METHYLDOPA
- STIMULASI α 2 NE PR , CO TD
- FARMAKOKINETIK :
PO : BIOAV < ( 25%)
( KONJUGASI O SULFAT DI MUCOSA GIT )
T ½ : 2 JAM EFEK : 4 – 6 JAM
- EF SAMPING : POSTURAL HIPOTENSI, REBOUND FENOMENA, SEDASI,
DEPRESI, VERTIGO, MATA KABUR, PROLACTIN ,
AN HEMOLITIK, HEPATITIS, FEVER, IMPOTENSI,
EXTRAPYRAMIDAL SYND
PR: periferal resistence
CO: cardiac Output
NE: norepinefrin
TD: Tekanan Darah
HYDRALAZINE
- DILATASI ARTERI
- MUDAH TACHYPHYLAXIS -> tolerans, untuk menimbulkan efek yang diharapkan
dosis semakin lama harus ditingkatkan
- PO : BIOAVAIL 25 % , T ½ 2 – 4 JAM
PROPRANOLOL
- UNTUK HT RINGAN / SEDANG
- KERJA BLOK β 1 & β 2
- EF RANGSANGAN : β 1 : CO , HR , RENIN
β 2 : VASODILATASI ( PR ), BROKODILATASI
METABOLISME KH
( INSULIN )
EF β BLOKER
MULA2 CO + BRADIKARDI TD CO NORMAL TD OK PR
RENIN TD
Brokokonstriksi, metbolisme karbohidrat turun, sekresi insulin turun->hiperglikemia
DOSIS PO > IV ( FIRST PASS METAB. )
TIMBULNYA BRADIKARDI ( EXERCISE )
INDIKATOR PENGATURAN DOSIS
EFEK SAMPING : BRADIKARDI, VASOKONSTR, BRONKONStriksi, DM, GG GIT,
hiperglikemia
TG meningkat, HDL turun-> memudahkan terbentuknya aterosklerosis.
(aterogenesis)
PEMBERIAN LAMA ………………..STOP (dihentikan mendadak)
WITH DRAWAL SYNDR
( = SUPER SENSITIVITY )
NERVOUS, TAKIKARDI, ANGINA, TD
ES : TG , HDL ATEROGENESIS
METOPROLOL
~ PROPRANOLOL BLOK β 1 (sensitif terhadap beta 1)
β 2 <<<(hambatannya sangat minimal)
( 50 – 100X < PROPRANOLOL )
BROKOKONSTR <<<
PINDOLOL – ACEBUTOLOL
- PR TD
- PENGARUH PD CO << β BLOKER LAIN
- PENGGUNAAN : GAGAL JTG, BRADY – ARITMIA, PENY VASKULAR PERIFER
Ada efek ISA (Intrinsik simpatomimetik activity, parsial agonis) positif.
LABETALOL
α - β BLOKER
RATIO BLOK β : α = 3 : 1
- TD OK PR
- CO TDK SIGNIFIKAN
- PENGGUNAAN : HT EMERGENSI
HT PHEOCROMOCYTOMA
GUANETIDINE
- MENCEGAH RELEASE NE
- DEPLATION NE STORAGE
IV…… RELEASE NE >>> TD
PO….. RELEASE NE PELAN DIRUSAK MAO
- KONTRA INDIKASI : PHEOCROMOCYTOMA
- EFEK : BLOK SYMP HIPOTENSI
- ES : SYMPATOPLEGIC POSTURAL HYPOTENSI
DIARE
HAMBAT EJAKULASI
PRAZOSIN
- BLOK α1 PD ARTERI – VENA
VASODILATASI TEKANAN ARTERI -> tekanan darah turun
- RETENSI Na / H2O sehingga penggunan harus KOMBINASI DGN
PROPANOLOL / DIURETIK
- DOSIS AWAL < HINDARI POSTURAL HIPOTENSI / SYNCOPE
- EF SAMPING : DIZZINESS, PALPITASI(berdebar debar), HEADACHE,
SEDASI, EDEM PERIFER, NAUSEA
- INDIKASI : - HIPERTENSI
- CHF (gagal jantung kolestif)
- PENY RAYNAUD (gannguan pembuluh darah perifer)
- BPH (pembesaran prostat jinak)
CALCIUM ANTAGONIS
MENCEGAH MASUKNYA Ca KE DALAM OTOT POLOS PEMBULUH DARAH
MENCEGAH TERJADINYA VASOKONSTRIKSI
VASODILATASI
DILTIAZEM NIFEDIPIN VERAPAMIL
VASODILATASI
KORONER
+ + + + + + _
VASODILATASI
PERIFER
+ + + + + +
HEART – RATE _ + + ±
KONTRAKSI
JANTUNG
O O / ± ±
+ = - =
Efek Samping Berdebar debar
-DILATASI OTOT POLOS : VASC, BRONCHUS, GIT, UTERIN
- ORTOSTATIK HIPOTENSI –
- REFL TAKIKARDI + ( N )
- SA NODE HR ( V / D )
- PLASMA DIGOXIN ( V )
- EFEK SAMPING : - VASC ( N ) HEADACHE, FLUSHING, DIZZINES
- EDEM PERIFER
- KONSTIPASI ( V )
- KONTRA INDIKASI : ARITMIA, GGL JTG (tidak boleh diberikan pada px)
- AMAN UNTK PX : ASMA, DISLIPIDEMI, DM
MINOXIDIL
- DIMETABOLISME MBTK MINOXIDIL SULFAT
MBUKA KANAL K+
OTOT POLOS DILATASI ARTERI ( VENA -)
- ANTI HT UNTK TX GGL GINJAL + HT BERAT
- T ½ 4 JAM, EF PERSISTEN SAMPAI 24 JAM
- REFL RANGS SYMP HINDARI DGN +
RETENSI NA+ / AIR β BLOKER / DIURETIK
EF SAMPING : TAKIKARDI, ANGINA, EDEMA
CAPTOPRIL
PO : CEPAT DIABSORBSI
DI IKAT MKN HRS PERUT KOSONG
BIOAV ± 70%
EF SSP Θ
KERJA : MHBT ACE EFEK :
1. TDK TBTK AT II
2. BRADYKININ TETAP AKTIF
SINTESA PG VASODILATOR TD
EFEK SAMPING :
- BATUK ± GG NAFAS(serasa tercekik), ANGIOUDEM
- HIPOTENSI
- Gagal Ginjal Akut, HIPERKALEMIA
KONTRA INDIKASI
- BUMIL MALFORMASI FETAL, HIPOTENSI, ANURIA, GGA
EFEK SAMPING PD YG LONG ACTING (FOSINOPRIL)
ENALAPRIL
- PRODRUG ENALAPRIL ABS PO CPT
- HYDROLISA MJD ENALAPRILATE (ACE INHBT)
ABS PO Θ
- ONSET < CAPTOPRIL
-ENALAPRILATE IV ONSET 15’
-DURATION OF ACTION OK IKATAN DG ACE KUAT (1X / h)
-INDIKASI : HT + GGL JTG (CHF)
-ES : RASH, ANGIOEDEM, BATUK, NEUTROPENIA, PROTEINURIA
SARALASIN = AT II ANTAGONIS
- STRUKTUR : ~ ANGIOTENSIN II
- “ KOMPETITIF INHIBISI “ (PARSIAL AGONIS)
- SEKR ALDOSTERON RETENSI Na +
- VASOKONSTR RINGAN (PX NON HT)
- VASODILATASI (PX HT)
- PEMBERIAN IV - - - - - - - (T½ BBRP MNT)
- TEK DRH - - - - - - - - -- - (PD.SEKRESI RENN )
(AGONIS)
DIURETIKA
THIAZIDE
1. MHBT REABS Na+
/ H2O
PENGELUARAN URIN >>
VOL DARAH Na+
RELATIF
Ca ++
(PEMB.DRH)
CO
SENSITIFITAS PEMB.DRH THD NE
TEK.DRH
2. VASODILATASI ARTERIOL TEK.DRH
* FARMAKOKINETIK
- ABS : PO BAIK
- EKS : REN (TANPA PERUBAHAN)
T½ < 4 JAM (EFEK 12 JAM)
* ES : 1. MHBT EKS ASAM URAT HYPERURISEMIA
2. M EKS K+
HYPOKALEMIA
3. MEMPENG METAB KH HYPERGLYKEMIA
4. MENINGKATKAN KOLESTEROL, LDL, TG
* CI : GAGAL GINJAL
* INTERAKSI :
TIAZID HYPOKALEMIA EF.DIGOKSIN
BHY KERACUNAN DIGITALIS
(BRADYKARDI, MUNTAH, GG.VISUAL)
OBAT LAIN
-POTASSIUM CHANNEL OPENER :
PINACIDIL
-SEROTONIN (5 – HT2) ANTAGONIS :
KETASERIN
-ANGIOTENSIN II REC ANTAGONIS :
LOSARTAN
SARALASIN
HAMIL + HIPERTENSI
-TENSI > 140 / 90
TX : METYLDOPA, HYDRALAZINE, β BLOKER (DIURETIC Θ)
-HT BERAT (T> 160 / 110)
TX : Β BLOKER (LABETALOL) IV
HYDRALAZINE (PARENTERAL / IV)
NIFEDIPIN (PO)
Mg SULFAT (U/ KEJANG)
-TDK DIANJURKAN :
-DIURETIK MEMPERBURUK PERFUSI
-ACE INHIB FETUS GGL GINJAL †
-RESERPIN TERATOGENIK
-NIFEDIPIN

More Related Content

Featured

2024 State of Marketing Report – by Hubspot
2024 State of Marketing Report – by Hubspot2024 State of Marketing Report – by Hubspot
2024 State of Marketing Report – by HubspotMarius Sescu
 
Everything You Need To Know About ChatGPT
Everything You Need To Know About ChatGPTEverything You Need To Know About ChatGPT
Everything You Need To Know About ChatGPTExpeed Software
 
Product Design Trends in 2024 | Teenage Engineerings
Product Design Trends in 2024 | Teenage EngineeringsProduct Design Trends in 2024 | Teenage Engineerings
Product Design Trends in 2024 | Teenage EngineeringsPixeldarts
 
How Race, Age and Gender Shape Attitudes Towards Mental Health
How Race, Age and Gender Shape Attitudes Towards Mental HealthHow Race, Age and Gender Shape Attitudes Towards Mental Health
How Race, Age and Gender Shape Attitudes Towards Mental HealthThinkNow
 
AI Trends in Creative Operations 2024 by Artwork Flow.pdf
AI Trends in Creative Operations 2024 by Artwork Flow.pdfAI Trends in Creative Operations 2024 by Artwork Flow.pdf
AI Trends in Creative Operations 2024 by Artwork Flow.pdfmarketingartwork
 
PEPSICO Presentation to CAGNY Conference Feb 2024
PEPSICO Presentation to CAGNY Conference Feb 2024PEPSICO Presentation to CAGNY Conference Feb 2024
PEPSICO Presentation to CAGNY Conference Feb 2024Neil Kimberley
 
Content Methodology: A Best Practices Report (Webinar)
Content Methodology: A Best Practices Report (Webinar)Content Methodology: A Best Practices Report (Webinar)
Content Methodology: A Best Practices Report (Webinar)contently
 
How to Prepare For a Successful Job Search for 2024
How to Prepare For a Successful Job Search for 2024How to Prepare For a Successful Job Search for 2024
How to Prepare For a Successful Job Search for 2024Albert Qian
 
Social Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie InsightsSocial Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie InsightsKurio // The Social Media Age(ncy)
 
Trends In Paid Search: Navigating The Digital Landscape In 2024
Trends In Paid Search: Navigating The Digital Landscape In 2024Trends In Paid Search: Navigating The Digital Landscape In 2024
Trends In Paid Search: Navigating The Digital Landscape In 2024Search Engine Journal
 
5 Public speaking tips from TED - Visualized summary
5 Public speaking tips from TED - Visualized summary5 Public speaking tips from TED - Visualized summary
5 Public speaking tips from TED - Visualized summarySpeakerHub
 
ChatGPT and the Future of Work - Clark Boyd
ChatGPT and the Future of Work - Clark Boyd ChatGPT and the Future of Work - Clark Boyd
ChatGPT and the Future of Work - Clark Boyd Clark Boyd
 
Getting into the tech field. what next
Getting into the tech field. what next Getting into the tech field. what next
Getting into the tech field. what next Tessa Mero
 
Google's Just Not That Into You: Understanding Core Updates & Search Intent
Google's Just Not That Into You: Understanding Core Updates & Search IntentGoogle's Just Not That Into You: Understanding Core Updates & Search Intent
Google's Just Not That Into You: Understanding Core Updates & Search IntentLily Ray
 
Time Management & Productivity - Best Practices
Time Management & Productivity -  Best PracticesTime Management & Productivity -  Best Practices
Time Management & Productivity - Best PracticesVit Horky
 
The six step guide to practical project management
The six step guide to practical project managementThe six step guide to practical project management
The six step guide to practical project managementMindGenius
 
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...RachelPearson36
 

Featured (20)

2024 State of Marketing Report – by Hubspot
2024 State of Marketing Report – by Hubspot2024 State of Marketing Report – by Hubspot
2024 State of Marketing Report – by Hubspot
 
Everything You Need To Know About ChatGPT
Everything You Need To Know About ChatGPTEverything You Need To Know About ChatGPT
Everything You Need To Know About ChatGPT
 
Product Design Trends in 2024 | Teenage Engineerings
Product Design Trends in 2024 | Teenage EngineeringsProduct Design Trends in 2024 | Teenage Engineerings
Product Design Trends in 2024 | Teenage Engineerings
 
How Race, Age and Gender Shape Attitudes Towards Mental Health
How Race, Age and Gender Shape Attitudes Towards Mental HealthHow Race, Age and Gender Shape Attitudes Towards Mental Health
How Race, Age and Gender Shape Attitudes Towards Mental Health
 
AI Trends in Creative Operations 2024 by Artwork Flow.pdf
AI Trends in Creative Operations 2024 by Artwork Flow.pdfAI Trends in Creative Operations 2024 by Artwork Flow.pdf
AI Trends in Creative Operations 2024 by Artwork Flow.pdf
 
Skeleton Culture Code
Skeleton Culture CodeSkeleton Culture Code
Skeleton Culture Code
 
PEPSICO Presentation to CAGNY Conference Feb 2024
PEPSICO Presentation to CAGNY Conference Feb 2024PEPSICO Presentation to CAGNY Conference Feb 2024
PEPSICO Presentation to CAGNY Conference Feb 2024
 
Content Methodology: A Best Practices Report (Webinar)
Content Methodology: A Best Practices Report (Webinar)Content Methodology: A Best Practices Report (Webinar)
Content Methodology: A Best Practices Report (Webinar)
 
How to Prepare For a Successful Job Search for 2024
How to Prepare For a Successful Job Search for 2024How to Prepare For a Successful Job Search for 2024
How to Prepare For a Successful Job Search for 2024
 
Social Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie InsightsSocial Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie Insights
 
Trends In Paid Search: Navigating The Digital Landscape In 2024
Trends In Paid Search: Navigating The Digital Landscape In 2024Trends In Paid Search: Navigating The Digital Landscape In 2024
Trends In Paid Search: Navigating The Digital Landscape In 2024
 
5 Public speaking tips from TED - Visualized summary
5 Public speaking tips from TED - Visualized summary5 Public speaking tips from TED - Visualized summary
5 Public speaking tips from TED - Visualized summary
 
ChatGPT and the Future of Work - Clark Boyd
ChatGPT and the Future of Work - Clark Boyd ChatGPT and the Future of Work - Clark Boyd
ChatGPT and the Future of Work - Clark Boyd
 
Getting into the tech field. what next
Getting into the tech field. what next Getting into the tech field. what next
Getting into the tech field. what next
 
Google's Just Not That Into You: Understanding Core Updates & Search Intent
Google's Just Not That Into You: Understanding Core Updates & Search IntentGoogle's Just Not That Into You: Understanding Core Updates & Search Intent
Google's Just Not That Into You: Understanding Core Updates & Search Intent
 
How to have difficult conversations
How to have difficult conversations How to have difficult conversations
How to have difficult conversations
 
Introduction to Data Science
Introduction to Data ScienceIntroduction to Data Science
Introduction to Data Science
 
Time Management & Productivity - Best Practices
Time Management & Productivity -  Best PracticesTime Management & Productivity -  Best Practices
Time Management & Productivity - Best Practices
 
The six step guide to practical project management
The six step guide to practical project managementThe six step guide to practical project management
The six step guide to practical project management
 
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
 

Anti hypertensi-non-fk

  • 2. ETIOLOGI HT ESENSIAL : 90% SEKUNDER : - PENY GINJAL - TUMOR ADRENAL - KERACUNAN KEHAMILAN KOMPLIKASI HT - ISKEMIA JANTUNG ( PJK ) - GAGAL JANTUNG - GAGAL GINJAL - KEBUTAAN (perdarahan retina) - STROKE ( Cerebro Vasicular Accident ) hipertensi esensial/primer/idiopatik: krn 90% tidak diketahui penyebabnya hipertensi sekunder: diketahui penyebabnya.
  • 3. cat: jika ada vasokonstriksi Resistensi perifer^
  • 4.
  • 5. SSP SISTEM SIMPATIS PERIFER RELEASE NE STIMULASI JTG VASOKONSTRIKSI CARDIAC OUTPUT RESIST. PERIFER TEKANAN DARAH RENAL BLOOD FLOW EKSKRESI Na + AIR RELEASE RENIN ANGIOTENSINOGEN ANGIOTENSIN I AngiotensinCorbacte Enzim (dihambat dgan ACE inhibitor) AT II VASOKONSTR. SEKRS. ALDOSTERON RETENSI Na + AIR (penahanan Natrium) * RENIN PD : RBF , Na+ , CATHECOLAMIN, PG * AT II : PR TAPI CO TDK DIPENGARUHI PATOFISIOLOGI HIPERTENSI Θ 1, 2 Θ 3 Θ 4, 5 Θ 2, 6 RBF Na+ Θ 7 Θ 8 Θ 9
  • 6. TX NON FARMAKOLOGIS 1. KURANGI STRESS 2. OLAH RAGA HDL 3. BATASI GARAM 4. BB 5. STOP ROKOK & ALKOHOL
  • 7. • Ket: • Diobati dengan Angiotensin blocker. • 8: dihambat reseptor blocker • 9: dihambat dengan anti aldosteron
  • 8. ANTI HIPERTENSIANTI HIPERTENSI 1. α 2 AGONIS : CLONIDIN, METHYLDOPA 2. β BLOCKER : ATENOLOL, METOPROLOL, PROPANOLOL 3. BLOCK NEURON ADRENERGIK : GUANETIDIN 4. α 1 BLOCKER : TERAZOSIN, PRAZOSIN 1 SD 4 RELEASE NE VASOKONSTR CO 5. VASODILATOR - Ca ANTAGONIS : NIFEDIPIN, AMLODIPIN, VERAPAMIL, DILTIAZEM - DIRECT VASODILATOR : HIDRALAZIN, DIAZOKSID, MINOKSIDIL, NITROPRUSID 6. DIURETIK ( VOL PLASMA ) : HCT, FUROSEMID 7. ACE INHIBITOR : CAPTOPRIL, ENALAPRIL 8. AT II REC ANTAGONIS “ LOSARTAN 9. BLOK REC ALDOSTERON : SPIRONOLAKTON
  • 9. CLONIDINE -STIMULASI α2 DI SSP & PERIFER NE CO PR TEK DRH -FARMAKOKINETIK : T ½ 8 – 12 JAM, EKS GINJAL ( 50 % ) LARUT LEMAK, BIOAVAILABILITAS 75 % -EF SAMPING : SEDASI, MULUT KERING, DEPRESI, KONSTIPASI, IMPOTENSI, MIMPI BURUK, SYNDR PUTUS OBAT, POSTURAL HIPOTENSI JARANG -Postural hipotensi: harus tidur
  • 10. METHYLDOPA - STIMULASI α 2 NE PR , CO TD - FARMAKOKINETIK : PO : BIOAV < ( 25%) ( KONJUGASI O SULFAT DI MUCOSA GIT ) T ½ : 2 JAM EFEK : 4 – 6 JAM - EF SAMPING : POSTURAL HIPOTENSI, REBOUND FENOMENA, SEDASI, DEPRESI, VERTIGO, MATA KABUR, PROLACTIN , AN HEMOLITIK, HEPATITIS, FEVER, IMPOTENSI, EXTRAPYRAMIDAL SYND PR: periferal resistence CO: cardiac Output NE: norepinefrin TD: Tekanan Darah
  • 11. HYDRALAZINE - DILATASI ARTERI - MUDAH TACHYPHYLAXIS -> tolerans, untuk menimbulkan efek yang diharapkan dosis semakin lama harus ditingkatkan - PO : BIOAVAIL 25 % , T ½ 2 – 4 JAM
  • 12. PROPRANOLOL - UNTUK HT RINGAN / SEDANG - KERJA BLOK β 1 & β 2 - EF RANGSANGAN : β 1 : CO , HR , RENIN β 2 : VASODILATASI ( PR ), BROKODILATASI METABOLISME KH ( INSULIN ) EF β BLOKER MULA2 CO + BRADIKARDI TD CO NORMAL TD OK PR RENIN TD Brokokonstriksi, metbolisme karbohidrat turun, sekresi insulin turun->hiperglikemia DOSIS PO > IV ( FIRST PASS METAB. )
  • 13. TIMBULNYA BRADIKARDI ( EXERCISE ) INDIKATOR PENGATURAN DOSIS EFEK SAMPING : BRADIKARDI, VASOKONSTR, BRONKONStriksi, DM, GG GIT, hiperglikemia TG meningkat, HDL turun-> memudahkan terbentuknya aterosklerosis. (aterogenesis) PEMBERIAN LAMA ………………..STOP (dihentikan mendadak) WITH DRAWAL SYNDR ( = SUPER SENSITIVITY ) NERVOUS, TAKIKARDI, ANGINA, TD ES : TG , HDL ATEROGENESIS
  • 14. METOPROLOL ~ PROPRANOLOL BLOK β 1 (sensitif terhadap beta 1) β 2 <<<(hambatannya sangat minimal) ( 50 – 100X < PROPRANOLOL ) BROKOKONSTR <<< PINDOLOL – ACEBUTOLOL - PR TD - PENGARUH PD CO << β BLOKER LAIN - PENGGUNAAN : GAGAL JTG, BRADY – ARITMIA, PENY VASKULAR PERIFER Ada efek ISA (Intrinsik simpatomimetik activity, parsial agonis) positif.
  • 15. LABETALOL α - β BLOKER RATIO BLOK β : α = 3 : 1 - TD OK PR - CO TDK SIGNIFIKAN - PENGGUNAAN : HT EMERGENSI HT PHEOCROMOCYTOMA
  • 16. GUANETIDINE - MENCEGAH RELEASE NE - DEPLATION NE STORAGE IV…… RELEASE NE >>> TD PO….. RELEASE NE PELAN DIRUSAK MAO - KONTRA INDIKASI : PHEOCROMOCYTOMA - EFEK : BLOK SYMP HIPOTENSI - ES : SYMPATOPLEGIC POSTURAL HYPOTENSI DIARE HAMBAT EJAKULASI
  • 17. PRAZOSIN - BLOK α1 PD ARTERI – VENA VASODILATASI TEKANAN ARTERI -> tekanan darah turun - RETENSI Na / H2O sehingga penggunan harus KOMBINASI DGN PROPANOLOL / DIURETIK - DOSIS AWAL < HINDARI POSTURAL HIPOTENSI / SYNCOPE - EF SAMPING : DIZZINESS, PALPITASI(berdebar debar), HEADACHE, SEDASI, EDEM PERIFER, NAUSEA - INDIKASI : - HIPERTENSI - CHF (gagal jantung kolestif) - PENY RAYNAUD (gannguan pembuluh darah perifer) - BPH (pembesaran prostat jinak)
  • 18. CALCIUM ANTAGONIS MENCEGAH MASUKNYA Ca KE DALAM OTOT POLOS PEMBULUH DARAH MENCEGAH TERJADINYA VASOKONSTRIKSI VASODILATASI
  • 19. DILTIAZEM NIFEDIPIN VERAPAMIL VASODILATASI KORONER + + + + + + _ VASODILATASI PERIFER + + + + + + HEART – RATE _ + + ± KONTRAKSI JANTUNG O O / ± ± + = - = Efek Samping Berdebar debar
  • 20. -DILATASI OTOT POLOS : VASC, BRONCHUS, GIT, UTERIN - ORTOSTATIK HIPOTENSI – - REFL TAKIKARDI + ( N ) - SA NODE HR ( V / D ) - PLASMA DIGOXIN ( V ) - EFEK SAMPING : - VASC ( N ) HEADACHE, FLUSHING, DIZZINES - EDEM PERIFER - KONSTIPASI ( V ) - KONTRA INDIKASI : ARITMIA, GGL JTG (tidak boleh diberikan pada px) - AMAN UNTK PX : ASMA, DISLIPIDEMI, DM
  • 21. MINOXIDIL - DIMETABOLISME MBTK MINOXIDIL SULFAT MBUKA KANAL K+ OTOT POLOS DILATASI ARTERI ( VENA -) - ANTI HT UNTK TX GGL GINJAL + HT BERAT - T ½ 4 JAM, EF PERSISTEN SAMPAI 24 JAM - REFL RANGS SYMP HINDARI DGN + RETENSI NA+ / AIR β BLOKER / DIURETIK EF SAMPING : TAKIKARDI, ANGINA, EDEMA
  • 22. CAPTOPRIL PO : CEPAT DIABSORBSI DI IKAT MKN HRS PERUT KOSONG BIOAV ± 70% EF SSP Θ KERJA : MHBT ACE EFEK : 1. TDK TBTK AT II 2. BRADYKININ TETAP AKTIF SINTESA PG VASODILATOR TD
  • 23. EFEK SAMPING : - BATUK ± GG NAFAS(serasa tercekik), ANGIOUDEM - HIPOTENSI - Gagal Ginjal Akut, HIPERKALEMIA KONTRA INDIKASI - BUMIL MALFORMASI FETAL, HIPOTENSI, ANURIA, GGA EFEK SAMPING PD YG LONG ACTING (FOSINOPRIL)
  • 24. ENALAPRIL - PRODRUG ENALAPRIL ABS PO CPT - HYDROLISA MJD ENALAPRILATE (ACE INHBT) ABS PO Θ - ONSET < CAPTOPRIL -ENALAPRILATE IV ONSET 15’ -DURATION OF ACTION OK IKATAN DG ACE KUAT (1X / h) -INDIKASI : HT + GGL JTG (CHF) -ES : RASH, ANGIOEDEM, BATUK, NEUTROPENIA, PROTEINURIA
  • 25. SARALASIN = AT II ANTAGONIS - STRUKTUR : ~ ANGIOTENSIN II - “ KOMPETITIF INHIBISI “ (PARSIAL AGONIS) - SEKR ALDOSTERON RETENSI Na + - VASOKONSTR RINGAN (PX NON HT) - VASODILATASI (PX HT) - PEMBERIAN IV - - - - - - - (T½ BBRP MNT) - TEK DRH - - - - - - - - -- - (PD.SEKRESI RENN ) (AGONIS)
  • 26. DIURETIKA THIAZIDE 1. MHBT REABS Na+ / H2O PENGELUARAN URIN >> VOL DARAH Na+ RELATIF Ca ++ (PEMB.DRH) CO SENSITIFITAS PEMB.DRH THD NE TEK.DRH
  • 27. 2. VASODILATASI ARTERIOL TEK.DRH * FARMAKOKINETIK - ABS : PO BAIK - EKS : REN (TANPA PERUBAHAN) T½ < 4 JAM (EFEK 12 JAM) * ES : 1. MHBT EKS ASAM URAT HYPERURISEMIA 2. M EKS K+ HYPOKALEMIA 3. MEMPENG METAB KH HYPERGLYKEMIA 4. MENINGKATKAN KOLESTEROL, LDL, TG * CI : GAGAL GINJAL * INTERAKSI : TIAZID HYPOKALEMIA EF.DIGOKSIN BHY KERACUNAN DIGITALIS (BRADYKARDI, MUNTAH, GG.VISUAL)
  • 28. OBAT LAIN -POTASSIUM CHANNEL OPENER : PINACIDIL -SEROTONIN (5 – HT2) ANTAGONIS : KETASERIN -ANGIOTENSIN II REC ANTAGONIS : LOSARTAN SARALASIN
  • 29. HAMIL + HIPERTENSI -TENSI > 140 / 90 TX : METYLDOPA, HYDRALAZINE, β BLOKER (DIURETIC Θ) -HT BERAT (T> 160 / 110) TX : Β BLOKER (LABETALOL) IV HYDRALAZINE (PARENTERAL / IV) NIFEDIPIN (PO) Mg SULFAT (U/ KEJANG) -TDK DIANJURKAN : -DIURETIK MEMPERBURUK PERFUSI -ACE INHIB FETUS GGL GINJAL † -RESERPIN TERATOGENIK -NIFEDIPIN

Editor's Notes

  1. N: Nifedipin V:Verapamil D: diltiazem
  2. ACE Inhibitor:-&amp;gt; menurunkan angiotensin II -menghmbat inaktivasi bradikinin(brdaikini aktif)-&amp;gt;merangsang prostaglandin-&amp;gt;vasodilatasi -